- Home
- XGN vs OPRX Comparison
XGN vs OPRX Comparison
Compare XGN & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- OPRX
- Stock Information
- Founded
- XGN 2002
- OPRX 2006
- Country
- XGN United States
- OPRX United States
- Employees
- XGN N/A
- OPRX N/A
- Industry
- XGN Medical Specialities
- OPRX Business Services
- Sector
- XGN Health Care
- OPRX Consumer Discretionary
- Exchange
- XGN Nasdaq
- OPRX Nasdaq
- Market Cap
- XGN 138.3M
- OPRX 154.9M
- IPO Year
- XGN 2019
- OPRX N/A
- Fundamental
- Price
- XGN $6.92
- OPRX $12.23
- Analyst Decision
- XGN Strong Buy
- OPRX Buy
- Analyst Count
- XGN 2
- OPRX 8
- Target Price
- XGN $7.50
- OPRX $10.38
- AVG Volume (30 Days)
- XGN 374.9K
- OPRX 329.8K
- Earning Date
- XGN 05-05-2025
- OPRX 05-12-2025
- Dividend Yield
- XGN N/A
- OPRX N/A
- EPS Growth
- XGN N/A
- OPRX N/A
- EPS
- XGN N/A
- OPRX N/A
- Revenue
- XGN $56,724,000.00
- OPRX $94,365,000.00
- Revenue This Year
- XGN $19.39
- OPRX $13.85
- Revenue Next Year
- XGN $13.27
- OPRX $11.15
- P/E Ratio
- XGN N/A
- OPRX N/A
- Revenue Growth
- XGN 1.78
- OPRX 20.66
- 52 Week Low
- XGN $1.71
- OPRX $3.78
- 52 Week High
- XGN $7.20
- OPRX $12.78
- Technical
- Relative Strength Index (RSI)
- XGN 62.02
- OPRX 62.62
- Support Level
- XGN $6.51
- OPRX $11.75
- Resistance Level
- XGN $7.20
- OPRX $12.77
- Average True Range (ATR)
- XGN 0.51
- OPRX 0.97
- MACD
- XGN 0.04
- OPRX 0.01
- Stochastic Oscillator
- XGN 81.15
- OPRX 80.47
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.